inmediQ

Let's make cardiovascular deaths history

inmediQ was founded in 2020 with the mission to make cardiovascular prevention more precise, accessible, and earlier. Building on decades of cardiovascular expertise, the company focuses on detecting risk long before disease becomes irreversible. Its proprietary VasioCore® system is based on the Cardiovascular Twin concept, capturing high-resolution pulse-wave signals and translating them into patient-specific vascular and cardiac insights through model-based inference. This world-first approach enables individualized risk profiling and early detection of subclinical cardiovascular changes non-invasively and pain-free. inmediQ aims to democratize cardiovascular prevention by enabling scalable, low-threshold integration into preventive care and population-level screening, shifting care from reaction to early insight.